Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ROSSARI BIOTECH LIMITED Call Transcript 2021

Jul 30, 2021

59144_rns_2021-07-30_ba394e62-4bd5-482d-b707-65f268a43159.pdf

Call Transcript

Open in viewer

Opens in your device viewer

July 30, 2021

DCS-CRDBSE LimitedFirst Floor, New Trade WingRotunda Building, Phiroze Jeejeebhoy TowersDalal Street, Fort Mumbai 400 023Fax No.2272 3121/2037/2039Stock Code: 543213 Listing ComplianceNational Stock Exchange of India Ltd.Exchange Plaza, 5th FloorPlot No.C/1, ‘G’Block, Bandra- KurlaComplexBandra East Mumbai 400 051Fax No.2659 8237/8238Stock Code: ROSSARI

Dear Sir/Madam,

Sub: Revision in Timing of Earnings Conference Call for investors and analysts for Q1 FY2122.

Please refer to our intimation letter dated July 26, 2021 wherein we have informed about hosting an Earnings Conference Call for investors and analysts for Q1 FY21-22 for discussing the results for the quarter ended June 30, 2021

In connection therewith, please be informed that due to unforeseen circumstances, the timing of the aforesaid call has been revised to 05:00 PM IST on Monday, August 02, 2021 other details remain unchanged.

The conference call will be initiated with a brief management discussion on the results for quarter ended June 30, 2021 followed by an interactive Question & Answer session.

Invite in this regard is enclosed for your information and record.

The same may please be taken on record and suitably disseminated to all concerned.

Thanking you,

Yours Sincerely,

For Rossari Biotech Limited

==> picture [85 x 47] intentionally omitted <==

==> picture [51 x 50] intentionally omitted <==

_______________________ Parul Gupta Company Secretary & Compliance Officer Membership No.: A38895

Encl.: as above

Type text here

==> picture [127 x 72] intentionally omitted <==

Rossari Biotech Limited

Q1 FY22 Earnings Conference Call

Monday, August 2, 2021 at 5:00 p.m. IST

Rossari Biotech Limited (Rossari) will host a conference call for investors and analysts on Monday, August 2, 2021 at 5:00 pm IST.

The conference call will be initiated with a brief management discussion on the Q1 FY22 results, to be declared on Friday, July 30, 2021, followed by an interactive Question & Answer session.

Senior Management team of the Company will be present to address the call.

Dial-in details are as follows:

Timing 5:00 p.m. IST on Monday, August 2, 2021
Universal dial-in + 91 22 6280 1141 / 7115 8042
Hong Kong Local Access Number 800 964 448
Singapore Local Access Number 800 101 2045
UK Local Access Number 0 808 101 1573
USA Local Access Number 1 866 746 2133
Pre-registration (Zero wait time to jointhe call) To enable participants to connect to the conference callwithout having to wait for an operator, please registerat the below mentioned link:

Please dial the below number 5-10 minutes prior to the scheduled start to ensure that you are connected to the call in time.

Page | 1

About Rossari:

Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Speciality-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates 2 strategically located manufacturing facilities at Silvassa and Dahej. The Company offers tailor-made solutions for Home, Personal Care and Performance chemicals (HPPC), Textile speciality chemicals and Animal Health and Nutrition (AHN). With differentiated product offerings, Rossari caters to an array of applications across FMCG, Home care, Industrial Cleaning, Personal Care, Textile Speciality Chemicals, Performance Chemicals, the Animal Health and Nutrition and Pet Care businesses. The Company has an extensive and a dedicated network of distributors spread all over India.

For more information, please visit www.rossari.com OR contact:

Manasi Nisal Anoop Poojari / Shikha Kshirsagar Rossari Biotech Limited CDR India Tel: +91 22 6123 3800 Tel: +91 98330 90434 Email: [email protected] Email: [email protected] [email protected]

DISCLAIMER:

Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and overseas, tax laws, import duties, litigation, labour relations etc. Actual results might differ substantially from those expressed or implied. Rossari Biotech Ltd will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

Page | 2